R. V. Jackson

464 total citations
23 papers, 378 citations indexed

About

R. V. Jackson is a scholar working on Cellular and Molecular Neuroscience, Behavioral Neuroscience and Molecular Biology. According to data from OpenAlex, R. V. Jackson has authored 23 papers receiving a total of 378 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cellular and Molecular Neuroscience, 6 papers in Behavioral Neuroscience and 5 papers in Molecular Biology. Recurrent topics in R. V. Jackson's work include Stress Responses and Cortisol (6 papers), Genetic Neurodegenerative Diseases (6 papers) and Parkinson's Disease Mechanisms and Treatments (4 papers). R. V. Jackson is often cited by papers focused on Stress Responses and Cortisol (6 papers), Genetic Neurodegenerative Diseases (6 papers) and Parkinson's Disease Mechanisms and Treatments (4 papers). R. V. Jackson collaborates with scholars based in Australia, United Kingdom and Germany. R. V. Jackson's co-authors include Jeffrey E. Grice, David J. Torpy, G. V. Crosbie, Margaret M. Walters, Emma Lynch, Alan R. Morton, Richard D. Gordon, Yvonne Burns, Stephen Nussey and Anthony W. Bachmann and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Thorax and Clinical Endocrinology.

In The Last Decade

R. V. Jackson

23 papers receiving 365 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. V. Jackson Australia 12 119 96 85 73 69 23 378
Erin K. Murphy United States 7 60 0.5× 105 1.1× 90 1.1× 99 1.4× 61 0.9× 14 445
G. Caffarri Italy 13 90 0.8× 82 0.9× 60 0.7× 173 2.4× 91 1.3× 40 444
N. Kinoshita Japan 7 76 0.6× 134 1.4× 55 0.6× 14 0.2× 43 0.6× 12 660
Teruhiko Hattori Japan 15 86 0.7× 257 2.7× 62 0.7× 154 2.1× 217 3.1× 25 545
A. K. Johnson United States 11 120 1.0× 43 0.4× 123 1.4× 44 0.6× 139 2.0× 13 484
Isaís Rada Venezuela 9 59 0.5× 81 0.8× 52 0.6× 36 0.5× 41 0.6× 12 373
Quilianio Contreras Venezuela 12 92 0.8× 22 0.2× 59 0.7× 82 1.1× 23 0.3× 15 380
G. L. Bernardini United States 8 111 0.9× 35 0.4× 56 0.7× 9 0.1× 34 0.5× 9 422
Harue Suzuki Japan 10 93 0.8× 34 0.4× 40 0.5× 15 0.2× 40 0.6× 19 341
J. M. Abrahams Australia 9 79 0.7× 56 0.6× 116 1.4× 32 0.4× 281 4.1× 16 398

Countries citing papers authored by R. V. Jackson

Since Specialization
Citations

This map shows the geographic impact of R. V. Jackson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. V. Jackson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. V. Jackson more than expected).

Fields of papers citing papers by R. V. Jackson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. V. Jackson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. V. Jackson. The network helps show where R. V. Jackson may publish in the future.

Co-authorship network of co-authors of R. V. Jackson

This figure shows the co-authorship network connecting the top 25 collaborators of R. V. Jackson. A scholar is included among the top collaborators of R. V. Jackson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. V. Jackson. R. V. Jackson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Khoo, Tien K., et al.. (2018). Respiratory dysfunction in myotonic dystrophy type 1: A systematic review. Neuromuscular Disorders. 29(3). 198–212. 43 indexed citations
2.
Dahiya, Arun, Tien K. Khoo, Matthew K. Burrage, et al.. (2018). Early Detection of Cardiac Structural and Functional Abnormalities in Adult Myotonic Dystrophy Type 1 Patients Using Advanced Cardiac Magnetic Resonance Imaging. Heart Lung and Circulation. 27. S236–S236. 1 indexed citations
3.
Torpy, David J. & R. V. Jackson. (2001). Adrenocorticotropin: Physiology and clinical aspects. Queensland's institutional digital repository (The University of Queensland). 153–159. 3 indexed citations
4.
Jackson, R. V., et al.. (2001). Early Rise In Blood Pressure Following Administration Of Adrenocorticotropic Hormone‐[1–24] In Humans. Clinical and Experimental Pharmacology and Physiology. 28(9). 773–775. 6 indexed citations
5.
Bornstein, SR, et al.. (2000). Interactions Between the Stimulated Hypothalamic‐Pituitary‐Adrenal Axis and Leptin in Humans. Journal of Neuroendocrinology. 12(2). 141–145. 24 indexed citations
6.
Burns, Yvonne, et al.. (1999). A longitudinal physical profile assessment of skeletal muscle manifestations in myotonic dystrophy. Clinical Rehabilitation. 13(1). 64–73. 28 indexed citations
7.
Jackson, R. V., et al.. (1999). A longitudinal physical profile assessment of skeletal muscle manifestations in myotonic dystrophy. Clinical Rehabilitation. 13(1_suppl). 64–73. 4 indexed citations
8.
Torpy, David J., et al.. (1997). DIURNAL EFFECTS OF FLUOXETINE AND NALOXONE ON THE HUMAN HYPOTHALAMIC‐PITUITARY‐ADRENAL AXIS. Clinical and Experimental Pharmacology and Physiology. 24(6). 421–423. 5 indexed citations
9.
Jackson, R. V., et al.. (1996). NEW DIAGNOSTIC TESTS FOR CUSHING'S SYNDROME: USES OF NALOXONE, VASOPRESSIN AND ALPRAZOLAM. Clinical and Experimental Pharmacology and Physiology. 23(6-7). 579–581. 4 indexed citations
10.
Jackson, R. V., et al.. (1994). Sleep hypoxia in myotonic dystrophy and its correlation with awake respiratory function.. Thorax. 49(1). 66–70. 41 indexed citations
11.
Torpy, David J., et al.. (1993). Alprazolam blocks the naloxone-stimulated hypothalamo-pituitary-adrenal axis in man.. The Journal of Clinical Endocrinology & Metabolism. 76(2). 388–391. 50 indexed citations
12.
Page, Sean, V. T. Y. Ang, R. V. Jackson, et al.. (1990). THE EFFECT OF OXYTOCIN INFUSION ON ADENOHYPOPHYSEAL FUNCTION IN MAN. Clinical Endocrinology. 32(3). 307–314. 35 indexed citations
13.
Obhrai, M., et al.. (1990). HORMONAL STUDIES ON WOMEN WITH POLYCYSTIC OVARIES DIAGNOSED BY ULTRASOUND. Clinical Endocrinology. 32(4). 467–474. 21 indexed citations
14.
Obhrai, M., et al.. (1990). Hormonal Studies on Women with Polycystic Ovaries Diagnosed by Ultrasound. Obstetrical & Gynecological Survey. 45(11). 761–762. 2 indexed citations
15.
Jackson, R. V., et al.. (1987). ADRENALINE INFUSION AND ADRENOCORTICOTROPHIN (ACTH) AND CORTISOL RELEASE IN NORMOTENSIVE AND HYPERTENSIVE MAN. Clinical and Experimental Pharmacology and Physiology. 14(3). 203–208. 6 indexed citations
16.
Saar, Nili, et al.. (1983). Different Norepinephrine Disappearance Rate in Venous and Arterial Plasma in Man. Clinical and Experimental Hypertension Part A Theory and Practice. 5(1). 31–40. 5 indexed citations
17.
Jackson, R. V., et al.. (1983). LONG TERM MINOXIDIL THERAPY and RENAL FUNCTION, CARDIAC FUNCTION, HYPERTRICHOSIS and BLOOD PRESSURE. Australian and New Zealand Journal of Medicine. 13(1). 39–44. 8 indexed citations
18.
Jackson, R. V., et al.. (1983). Factors affecting the frequency of occurrence of spironolactone bodies in aldosteronomas and non-tumorous cortex. Pathology. 15(3). 273–277. 6 indexed citations
19.
Jackson, R. V., et al.. (1983). Increased sympathetic activity in renovascular hypertension in man.. PubMed. 9(3). 277–81. 18 indexed citations
20.
Jackson, R. V., et al.. (1977). Use of a Microprocessor in the Control of Malignant Hypertension with Sodium Nitroprusside. Australian and New Zealand Journal of Medicine. 7(4). 414–417. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Erin K. Murphy Breakdown of academic impact, for papers by G. Caffarri Breakdown of academic impact, for papers by N. Kinoshita Breakdown of academic impact, for papers by Teruhiko Hattori Breakdown of academic impact, for papers by A. K. Johnson Breakdown of academic impact, for papers by Isaís Rada Breakdown of academic impact, for papers by Quilianio Contreras Breakdown of academic impact, for papers by G. L. Bernardini Breakdown of academic impact, for papers by Harue Suzuki Breakdown of academic impact, for papers by J. M. Abrahams
Rankless by CCL
2026